Literature DB >> 16309926

Is primidone the drug of choice for epileptic patients with QT-prolongation? A comprehensive analysis of literature.

D Christidis1, D Kalogerakis, T Y Chan, D Mauri, G Alexiou, A Terzoudi.   

Abstract

Sudden unexplained/unexpected death (SUDEP) in epilepsy is a major cause of death accounting for 7-17% of the mortality among epileptic patients. Prolongation of QT-interval has been issued as a major mechanism in SUDEP since it is associated with fatal cardiac arrhythmias. This condition may be further precipitated by anti-epileptic treatment. Despite thorough literature research, we did not find any reports suggesting that primidone is responsible for QT-prolongation. On the contrary, all the retrieved reports addressed that the drug shortened QT-interval and corrected signs and symptoms of the underlying disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16309926     DOI: 10.1016/j.seizure.2005.10.002

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  2 in total

1.  A null mutation of the neuronal sodium channel NaV1.6 disrupts action potential propagation and excitation-contraction coupling in the mouse heart.

Authors:  Sami F Noujaim; Kuljeet Kaur; Michelle Milstein; Julie M Jones; Philip Furspan; Daniel Jiang; David S Auerbach; Todd Herron; Miriam H Meisler; José Jalife
Journal:  FASEB J       Date:  2011-09-24       Impact factor: 5.191

2.  Risk of cardiac events in Long QT syndrome patients when taking antiseizure medications.

Authors:  David S Auerbach; Yitschak Biton; Bronislava Polonsky; Scott McNitt; Robert A Gross; Robert T Dirksen; Arthur J Moss
Journal:  Transl Res       Date:  2017-10-20       Impact factor: 7.012

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.